actually, if you extend the time allowed for companies to keep their patents, the costs will be lower, because the company will have a longer period of time in which to recoup their R&D.
the patent running out is the only reason that generics can be produced
the pharms will not lower the cost of a drug until that happens
my wife audited a couple of the big pharms in her public accounting days, they ain't voluntarily lowering any prices
